Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice

Immunobiology

Volumn 214, Issue 6, 2009, Pages 467-474

  Cabrera, Alex ^a   Sáez, Darwin ^a   Céspedes, Sandra ^a   Andrews, Edilia ^a   Oñate, Angel ^a  

^a Faculty of Biological Sciences   (Chile)

Author keywords

Brucella abortus; Brucellosis; IF3; Immunogenicity; RNA vaccine; Translation initiation factor 3

Indexed keywords

BACTERIAL PROTEIN; BRUCELLA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN M ANTIBODY; INITIATION FACTOR 3; INTERLEUKIN 4; RECOMBINANT INITIATION FACTOR 3; RECOMBINANT PROTEIN; RNA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL VIRULENCE; BRUCELLA ABORTUS; BRUCELLOSIS; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; INFECTION RESISTANCE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REPLICON; SEMLIKI FOREST ALPHAVIRUS; SPLEEN CELL; T LYMPHOCYTE; VIRUS PARTICLE; VIRUS RECOMBINANT;

ALPHAVIRUS INFECTIONS; ANIMALS; BRUCELLA ABORTUS; EUKARYOTIC INITIATION FACTORS; GENETIC ENGINEERING; IMMUNITY, ACTIVE; MICE; MICE, INBRED BALB C; PROKARYOTIC INITIATION FACTOR-3; RECOMBINATION, GENETIC; SEMLIKI FOREST VIRUS; VACCINATION; VIRULENCE;

EID: 64649085570     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.11.016     Document Type: Article

References (45)

1. Al-Mariri A., Tibor A., Mertens P., De Bolle X., Michel P., Godfroid J., Walravens K., and Letesson J.J. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect. Immun. 69 (2001) 6264-6270
2. Andersson C., Vasconcelos N., Sievertzon M., Haddad D., Liljeqvist S., Berglund P., Liljeström P., Ahlborg M., Ståhl S., and Berzins K. Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332. Scand. J. Immunol. 54 (2001) 117-124
3. Ashford D.A., di Pietra J., Lingappa J., Woods C., Noll H., Neville B., Weyant R., Bragg S.L., Spiegel R.A., Tappero J., and Perkins B.A. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 22 (2004) 3435-3439
4. Berglund P., Fleeton M.N., Smerdou C., and Liljestrom P. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. Vaccine 17 (1999) 497-507
5. Brand D., Lemiale F., Turbica I., Buzelay L., Brunet S., and Barin F. Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles. AIDS Res. Hum. Retroviruses 14 (1998) 1369-1377
6. Céspedes S., Andrews E., Folch H., and Oñate A. Identification and partial characterisation of a new protective antigen of Brucella abortus. J. Med. Microbiol. 49 (2000) 165-170
7. Cheville N.F., Olsen S.C., Jensen A.E., Stevens M.G., Palmer M.V., and Florance A.M. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. Am. J. Vet. Res. 57 (1996) 1153-1156
8. Confer A.W., Hall S.M., Faulkner C.B., Espe B.H., Deyoe B.L., Morton R.J., and Smith R.A. Effects of challenge dose on the clinical and immune responses of cattle vaccinated with reduced doses of Brucella abortus strain 19. Vet. Microbiol. 10 (1985) 561-575
9. Corbel M.J. Brucellosis: an overview. Emerg. Infect. Dis. 3 (1997) 213-221
10. Corner L.A., and Alton G.G. Persistence of Brucella abortus strain 19 infection in adult cattle vaccinated with reduced doses. Res. Vet. Sci. 31 (1981) 342-344
11. Dalton D.K., Haynes L., Chu C.Q., Swain S.L., and Wittmer S. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med. 192 (2000) 117-122
12. Fleeton M.N., Sheahan B.J., Gould E.A., Atkins G.J., and Liljeström P. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge. J. Gen. Virol. 80 (1999) 1189-1198
13. Fleeton M.N., Liljeström P., Sheahan B., and Atkins G. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine. J. Gen. Virol. 81 (2000) 749-758
14. Frolov I., Hoffman T.A., Prágai B.M., Dryga S.A., Huang H.V., Schlesinger S., and Rice C.M. Alphavirus-based expression vectors: strategies and applications. Proc. Natl. Acad. Sci. USA 93 (1996) 11371-11377
15. Golding B., Scott D.E., Scharf O., Huang L.Y., Zaitseva M., Lapham C., Eller N., and Golding H. Immunity and protection against Brucella abortus. Microbes Infect. 3 (2001) 43-48
16. González, M., Andrews, E., Folch, H., Sáez, D., Cabrera, C., Salgado, P., Oñate, A., 2008. Cloning, expression and immunogenicity of the translation initiation factor 3 homologue of Brucella abortus. Immunobiology, doi:10.1016/j.imbio.2008.07.004.
17. He Y., Vemulapalli R., Zeytun A., and Schurig G.G. Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect. Immun. 69 (2001) 5502-5508
18. Jiang X., and Baldwin C.L. Effects of cytokines on intracellular growth of Brucella abortus. Infect. Immun. 61 (1993) 124-134
19. Jones S., and Winter A.J. Survival of virulent and attenuated strain of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages. Infect. Immun. 60 (1992) 3011-3014
20. Ko J., and Splitter G. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16 (2003) 65-78
21. Koopman G., Mortier D., Hofman S., Niphuis H., Fagrouch Z., Norley S., Sutter G., Liljestrom P., and Heeney J.L. Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens. J. Gen. Virol. 85 (2004) 2915-2924
22. Li N., Zhao J.J., Zhao H.P., Sun Y., Zhu Q.H., Tong G.Z., and Qiu H.J. Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus. J. Virol. Methods 144 (2007) 73-78
23. Liljeström P., and Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology 9 (1991) 1356-1361
24. Lundstrom K. Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim. Biophys. Acta 1610 (2003) 90-96
25. Murphy M.P. Nitric oxide and cell death. Biochim. Biophys. Acta 1411 (1999) 401-414
26. Murphy E.A., Sarhiyaseelam J., Parent M.A., Zou B., and Baldwin C.L. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 1003 (2001) 511-518
27. Nilsson C., Mäkitalo B., Berglund P., Bex F., Liljeström P., Sutter G., Erfle V., ten Haaft P., Heeney J., Biberfeld G., and Thorstensson R. Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara. Vaccine 19 (2001) 3526-3536
28. RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur. J. Immunol. 25 (1995) 2551-2557
29. Oliveira S.C., and Splitter G.A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14 (1996) 959-962
30. Oliveira S.C., Harms J.S., Rech E.L., Rodarte R.S., Bocca A.L., Goes A.M., and Splitter G.A. The role of T cell subsets and cytokines in the regulation of intracellular bacterial infection. Braz. J. Med. Biol. Res. 31 (1998) 77-84
31. Oñate A.A., Vemulapalli R., Andrews E., Schurig G.G., Boyle S., and Folch H. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect. Immun. 67 (1999) 986-988
32. Oñate A.A., Céspedes S., Cabrera A., Rivers R., González A., Muñoz C., Folch H., and Andrews E. A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 71 (2003) 4857-4861
33. Oñate A.A., Donoso G., Moraga-Cid G., Folch H., Cespedes S., and Andrews E. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 73 (2005) 3294-3300
34. Oñate A.E., Andrews E., Beltran A., Eller G., Schurig G., and Folch H. Frequent exposure of mice to crude Brucella abortus proteins down-regulates immune response. J. Vet. Med. 47 (2000) 677-682
35. Palmer M.V., Cheville N.F., and Jensen A.E. Experimental infection of pregnant cattle with the vaccine candidate Brucella abortus strain RB51: pathologic, bacteriologic, and serologic findings. Vet. Pathol. 33 (1996) 682-691
36. Penttila T., Tammiruusu A., Liljestrom P., Sarvas M., Makela P.H., Vuola J.M., and Puolakkainen M. DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model. Vaccine 22 (2004) 3386-3394
37. Polo J.M., Belli B.A., Driver D.A., Frolov I., Sherrill S., Hariharan M.J., Townsend K., Perri S., Mento S.J., Jolly D.J., Chang S.M., Schlesinger S., and Dubensky Jr. T.W. Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors. Proc. Natl. Acad. Sci. USA 96 (1999) 4598-4603
38. Saez D., Guzman I., Andrews E., Cabrera A., and Onate A. Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle. Vet. Microbiol. 129 (2008) 396-403
39. Schlesinger S. Alphavirus vectors: development and potential therapeutic applications. Expert Opin. Biol. Therapy 1 (2001) 177-191
40. Smith L.D., and Ficht T.A. Pathogenesis of Brucella. Crit. Rev. Microbiol. 17 (1990) 209-230
41. Velikovsky C.A., Cassataro J., Giambartolomei G.H., Goldbaum F.A., Estein S., Bowden R.A., Bruno L., Fossati C.A., and Spitz M.A. DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 70 (2002) 2507-2511
42. Williams M.S., Noguchi S., Henkart P.A., and Osawa Y. Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J. Immunol. 161 (1998) 6526-6531
43. Yu X., Xiao S., Fang L., Jiang Y., and Chen H. Enhanced immunogenicity to food-and-mouth disease virus in mice vaccination with alphaviral replicon-based DNA vaccine expressing the capsid precursor polypeptide (P1). Virus Genes 33 (2006) 337-344
44. Zhan Y., and Cheers C. Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect. Immun. 61 (1993) 4899-4901
45. Zhou X., Berglund P., Rhodes G., Parker S.E., Jondal M., and Liljeström P. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12 (1994) 1510-1514